Company Description
SkinHealth Systems Inc., a global medical aesthetics company delivering an integrated ecosystem of clinically proven solutions in the Americas, the Asia-Pacific, Europe, the Middle East, Africa, Canada, and Latin America.
The company’s flagship product is HydraFacial, which enhances the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums.
It also offers Syndeo devices, which are delivery systems that are designed to connect providers to the consumer’s preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling and nanoneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive peptide solutions and take home sprays for treating scalp health.
In addition, it operates the MyBeautyHealth mobile application for consumers to earn loyalty points and unlock savings, log skin concerns and receive personalized treatment plans, and find and connect with Hydrafacial providers, as well as offers boosters.
The company was formerly known as The Beauty Health Company and changed its name to SkinHealth Systems Inc. in April 2026.
The company was founded in 1997 and is headquartered in Long Beach, California.
| Country | United States |
| Founded | 1997 |
| Industry | Household & Personal Products |
| Sector | Consumer Staples |
| Employees | 613 |
| CEO | Pedro Malha |
Contact Details
Address: 3600 E. Burnett Street Long Beach, California 90815 United States | |
| Phone | 800 603 4996 |
| Website | skinhealthsystems.com |
Stock Details
| Ticker Symbol | SKIN |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Share Class | Class A Shares |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 1818093 |
| CUSIP Number | 88331L108 |
| ISIN Number | US88331L1089 |
| Employer ID | 85-1908962 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Pedro Malha | Chief Executive Officer, President and Director |
| Michael P. Monahan | Chief Financial Officer |
| Sheri Lewis | Chief Operations, Quality and Technology Officer |
| Ronald Menezes | Chief Revenue Officer and Executive Officer |
| Paul Bokota J.D. | Senior Vice President and General Counsel |
| Whitney Cypes | Chief Brand and Clinical Innovation Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| May 12, 2026 | 8-K | Current Report |
| May 11, 2026 | SCHEDULE 13D/A | Filing |
| May 7, 2026 | 10-Q | Quarterly Report |
| May 7, 2026 | 8-K | Current Report |
| May 6, 2026 | 8-K | Current Report |
| May 6, 2026 | SCHEDULE 13G/A | Filing |
| Apr 24, 2026 | ARS | Filing |
| Apr 24, 2026 | DEF 14A | Other definitive proxy statements |
| Apr 22, 2026 | 8-K | Current Report |
| Apr 20, 2026 | SCHEDULE 13G | Filing |